| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.31 | 3e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |